Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 492

1.

'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.

Staessen JA, Thijs L, Li Y, Kuznetsova T, Richart T, Wang J, Birkenhäger WH.

Curr Opin Cardiol. 2007 Jul;22(4):335-43. Review.

PMID:
17556887
2.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
3.

Update on the management of hypertension: recent clinical trials and the JNC 7.

Moser M.

J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):4-13. Review.

4.

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Staessen JA, Wang JG, Thijs L.

J Hypertens. 2003 Jun;21(6):1055-76.

PMID:
12777939
5.

Conventional therapy and newer drug classes for cardiovascular protection in hypertension.

Wang JG, Staessen JA.

J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S208-15. Review.

6.

High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?

Grossman E, Messerli FH, Goldbourt U.

Arch Intern Med. 2000 Sep 11;160(16):2447-52. Review.

PMID:
10979055
7.

Treatment of hypertension in patients with diabetes: lessons from recent trials.

Agarwal R.

Cardiol Rev. 2001 Jan-Feb;9(1):36-44. Review.

PMID:
11174914
9.

[Drug treatment of hypertension in hemodialysed patients].

Hannedouche T, Krumme T, Benaicha A, Bazin D.

Nephrol Ther. 2007 Oct;3 Suppl 3:S185-90. Review. French.

PMID:
18340685
10.

Systematic review: antihypertensive drug therapy in black patients.

Brewster LM, van Montfrans GA, Kleijnen J.

Ann Intern Med. 2004 Oct 19;141(8):614-27. Review.

PMID:
15492341
11.

Has the role of calcium channel blockers in treating hypertension finally been defined?

Chrysant GS, Chrysant SG.

Curr Hypertens Rep. 2003 Aug;5(4):295-300. Review.

PMID:
12844463
12.

Long-term safety of antihypertensive therapy.

Grossman E, Messerli FH.

Prog Cardiovasc Dis. 2006 Jul-Aug;49(1):16-25. Review.

PMID:
16867847
13.
14.

[Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].

Hildebrandt PR, Tuxen CD, Kjeldsen SE, Lund-Johansen P, Hansson L.

Ugeskr Laeger. 2001 Dec 31;164(1):18-21. Review. Danish.

PMID:
11810791
15.

Treatment of isolated systolic hypertension.

Stokes GS.

Curr Hypertens Rep. 2006 Oct;8(5):377-83. Review.

PMID:
16965723
16.

[Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].

Rajzer M, Kawecka-Jaszcz K, Wojciechowska W.

Przegl Lek. 2003;60(2):111-5. Review. Polish.

PMID:
12939858
17.
18.

Diuretics for cardiovascular prevention in the elderly.

Hanon O, Seux ML, Lenoir H, Rigaud AS, Girerd X, Forette F.

J Hum Hypertens. 2004 Dec;18 Suppl 2:S15-22. Review.

PMID:
15592568
19.

What can be expected from optimal blood pressure control?

Staessen JA, Wang JG, Thijs L.

J Hypertens Suppl. 2003 May;21(2):S3-9.

PMID:
12929901
20.

Initial antihypertensive therapy. What are the current drugs of choice?

Yeun JY.

Postgrad Med. 2001 Nov;110(5):39-40, 43-4, 47-8 passim. Review.

PMID:
11727652
Items per page

Supplemental Content

Support Center